220 related articles for article (PubMed ID: 37191789)
1. Generating Mitochondrial-Nuclear Exchange (MNX) Mice to Identify Mitochondrial Determinants of Cancer Metastasis.
Welch DR; Larson MA; Vivian CJ; Vivian JL
Methods Mol Biol; 2023; 2660():43-59. PubMed ID: 37191789
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Haplotype of the Host Stromal Microenvironment Alters Metastasis in a Non-cell Autonomous Manner.
Brinker AE; Vivian CJ; Beadnell TC; Koestler DC; Teoh ST; Lunt SY; Welch DR
Cancer Res; 2020 Mar; 80(5):1118-1129. PubMed ID: 31848195
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models.
Vivian CJ; Hagedorn TM; Jensen RA; Brinker AE; Welch DR
Cancer Metastasis Rev; 2018 Dec; 37(4):633-642. PubMed ID: 30547266
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the Roles of the Nuclear and Mitochondrial Genomes in a Mouse Model of Autoimmune Diabetes.
Zou W; Chezhian J; Yu T; Liu W; Vu J; Slone J; Huang T
Diabetes; 2024 Jan; 73(1):108-119. PubMed ID: 37847928
[TBL] [Abstract][Full Text] [Related]
5. The second genome: Effects of the mitochondrial genome on cancer progression.
Scheid AD; Beadnell TC; Welch DR
Adv Cancer Res; 2019; 142():63-105. PubMed ID: 30885364
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload.
Fetterman JL; Zelickson BR; Johnson LW; Moellering DR; Westbrook DG; Pompilius M; Sammy MJ; Johnson M; Dunham-Snary KJ; Cao X; Bradley WE; Zhang J; Wei CC; Chacko B; Schurr TG; Kesterson RA; Dell'italia LJ; Darley-Usmar VM; Welch DR; Ballinger SW
Biochem J; 2013 Oct; 455(2):157-67. PubMed ID: 23924350
[TBL] [Abstract][Full Text] [Related]
7. Roles of mitochondrial genetics in cancer metastasis.
Welch DR; Foster C; Rigoutsos I
Trends Cancer; 2022 Dec; 8(12):1002-1018. PubMed ID: 35915015
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Genomic Backgrounds Affect Nuclear DNA Methylation and Gene Expression.
Vivian CJ; Brinker AE; Graw S; Koestler DC; Legendre C; Gooden GC; Salhia B; Welch DR
Cancer Res; 2017 Nov; 77(22):6202-6214. PubMed ID: 28663334
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways.
Kaipparettu BA; Ma Y; Park JH; Lee TL; Zhang Y; Yotnda P; Creighton CJ; Chan WY; Wong LJ
PLoS One; 2013; 8(5):e61747. PubMed ID: 23671572
[TBL] [Abstract][Full Text] [Related]
10. Mutations in mitochondrial DNA regulate mitochondrial diseases and metastasis but do not regulate aging.
Hayashi JI; Hashizume O; Ishikawa K; Shimizu A
Curr Opin Genet Dev; 2016 Jun; 38():63-67. PubMed ID: 27078865
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Haplotype Alters Mammary Cancer Tumorigenicity and Metastasis in an Oncogenic Driver-Dependent Manner.
Brinker AE; Vivian CJ; Koestler DC; Tsue TT; Jensen RA; Welch DR
Cancer Res; 2017 Dec; 77(24):6941-6949. PubMed ID: 29070615
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction and cancer metastasis.
Chen EI
J Bioenerg Biomembr; 2012 Dec; 44(6):619-22. PubMed ID: 22892817
[TBL] [Abstract][Full Text] [Related]
13. Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer.
Beadnell TC; Scheid AD; Vivian CJ; Welch DR
Cancer Metastasis Rev; 2018 Dec; 37(4):615-632. PubMed ID: 30542781
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial genetics cooperate with nuclear genetics to selectively alter immune cell development/trafficking.
Beadnell TC; Fain C; Vivian CJ; King JCG; Hastings R; Markiewicz MA; Welch DR
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165648. PubMed ID: 31899295
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing.
Latorre-Pellicer A; Moreno-Loshuertos R; Lechuga-Vieco AV; Sánchez-Cabo F; Torroja C; Acín-Pérez R; Calvo E; Aix E; González-Guerra A; Logan A; Bernad-Miana ML; Romanos E; Cruz R; Cogliati S; Sobrino B; Carracedo Á; Pérez-Martos A; Fernández-Silva P; Ruíz-Cabello J; Murphy MP; Flores I; Vázquez J; Enríquez JA
Nature; 2016 Jul; 535(7613):561-5. PubMed ID: 27383793
[TBL] [Abstract][Full Text] [Related]
16.
Salminen TS; Vale PF
Front Immunol; 2020; 11():521. PubMed ID: 32269576
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA polymorphism and risk of cancer.
Singh KK; Kulawiec M
Methods Mol Biol; 2009; 471():291-303. PubMed ID: 19109786
[TBL] [Abstract][Full Text] [Related]
18. Attempts to understand the mechanisms of mitochondrial diseases: The reverse genetics of mouse models for mitochondrial disease.
Ishikawa K; Nakada K
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129835. PubMed ID: 33358867
[TBL] [Abstract][Full Text] [Related]
19. Mitohormesis, UPR
Kenny TC; Gomez ML; Germain D
Cancer Res; 2019 Dec; 79(24):6057-6066. PubMed ID: 31484668
[TBL] [Abstract][Full Text] [Related]
20. Understanding Mitochondrial Polymorphisms in Cancer.
Bussard KM; Siracusa LD
Cancer Res; 2017 Nov; 77(22):6051-6059. PubMed ID: 29097610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
